Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting Efficacy
NCT ID: NCT06219967
Last Updated: 2024-05-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
5 participants
INTERVENTIONAL
2023-01-04
2023-03-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Other studies have suggested that mixing AC with various substances improves the rating on various scales (taste, etc). An important question is whether mixing the AC with other substance effects the ability of the AC to bind to xenobiotic in the gut. This small study investigates whether mixed cola with charcoal affected its ability to prevent the absorption of acetaminophen. It also performs a survery to see if participants preferred the AC-cola mixture. The investigators hypothesize that the AC will be equally as effective with cola as without. The investigators also hypothesize that participants will prefer the AC-cola mixture.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Carbohydrates Part 2
NCT03293706
Efficacy of Different Doses of Amino Acids in 5AA+CrPic Water on Glucose Homeostasis in a Healthy Population.
NCT03411395
Acute Effects of Artificial Sweeteners or Sugar on Hemodynamic and Metabolic Stress Responses
NCT02973334
The Potentially Addictive Properties of Soda: A Feasibility Study
NCT02044757
Effects of Non-nutritive Sweeteners on the Composition of the Gut Microbiome
NCT02877186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Activated charcoal with cola
Activated Charcoal
Activated charcoal mixed with cola
Activated charcoal
Activated Charcoal
Activated charcoal alone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Activated Charcoal
Activated charcoal alone
Activated Charcoal
Activated charcoal mixed with cola
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No self-reported history of alcohol or substance use disorder
* No daily prescribed medications
* Weight between 60-93 kg
Exclusion Criteria
* imprisoned
* allergy or intolerance to acetaminophen or gluten
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York - Upstate Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Keenan
Assistant Professor Emergency Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SUNY Upstate Medical University Clinical Research Unit
Syracuse, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1783698-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.